TABLE 4 Summarized Patterns of Genetic Changes on Chromosome 8 in Stage T2–3N1–3M0 Prostate Cancer

From: Loss of p53 and c-myc Overrepresentation in Stage T2-3N1-3M0 Prostate Cancer are Potential Markers for Cancer Progression

Patterns

8pa

CEP8

c-myc

Number of Cancer Foci (%)

P Valueb

Number of Patients in Each Group (%)

P Valuec

    

Primary

Metastasis

 

Case

Control

 

1

Normal

Normal

Normal

6 (5)

1 (1)

.048

1 (4)

1 (4)

1.00

2

Loss

Normal

Normal

22 (18)

14 (12)

.45

2 (8)

4 (15)

.42

3

Loss

Loss

Normal

3 (3)

2 (2)

.57

0 (0)

0 (0)

4

Loss

Gain

Gain

45 (38)

63 (55)

.25

8 (31)

11 (42)

.37

5

Gain

Gain

Gain

6 (5)

1 (1)

.07

1 (4)

3 (12)

.34

6

Loss

Loss

Loss

2 (2)

0 (0)

0 (0)

1 (4)

.99

7

Normal

Normal

AI

4 (3)

1 (1)

.07

0 (0)

0 (0)

8

Loss

Normal

AI

7 (6)

8 (7)

.83

6 (23)

0 (0)

.10

9

Loss

Loss

AI

5 (4)

3 (3)

.81

1 (4)

2 (8)

.57

10

Loss

Gain

AI

18 (15)

14 (12)

.81

7 (26)

3 (12)

.21

11

Gain

Gain

AI

1 (1)

7 (6)

.08

0 (0)

0 (0)

Total

   

119 (100)

114 (100)

 

26 (100)

26 (100)

 
  1. aLoss of 8p in this table includes −8p and relative −8p (see definition in “Results”).
  2. bComparing primary tumor versus lymph node metastasis using GEE models.
  3. cComparing case group versus control group using conditional logistic regression.